CSL, WEHI, and the University of Melbourne have announced the appointment of an independent operator to oversee and manage a new start-up incubator that will support and grow early-stage Australian biotech companies.  

A world-first clinical trial platform launching in Melbourne is set to transform research into new therapies for brain cancer and deliver more targeted, personalised treatment for patients.  

Researchers have identified a new way to treat young children with Kawasaki Disease (KD) to prevent life-threatening coronary artery damage and heart attacks.

An international study that aims to discover the genes that cause stuttering has begun recruiting participants in the United Kingdom.